TY - JOUR
T1 - Impact of allergic symptoms on work productivity in allergic rhinitis
T2 - A MASK-air direct patient data study
AU - Vieira, Rafael José
AU - Pereira, Ana Margarida
AU - Kupczyk, Maciej
AU - Regateiro, Frederico S
AU - Larenas-Linnemann, Desirée E
AU - Toppila-Salmi, Sanna
AU - Iinuma, Tomohisa
AU - Kuna, Piotr
AU - Cruz, Alvaro A
AU - Brussino, Luisa
AU - Gemicioglu, Bilun
AU - Samolinski, Boleslaw
AU - Taborda-Barata, Luis
AU - Ventura, Maria Teresa
AU - Kvedariene, Violeta
AU - Klimek, Ludger
AU - Pfaar, Oliver
AU - Zuberbier, Torsten
AU - Azevedo, Luís Filipe
AU - Fonseca, João A
AU - Bousquet, Jean
AU - Sousa-Pinto, Bernardo
AU - MASK‐air think tank
A2 - Porsbjerg, Celeste
N1 - Copyright © 2025 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.
PY - 2025/7
Y1 - 2025/7
N2 - BACKGROUND: Allergic rhinitis may impair work productivity. This study aimed to assess (i) the differential impact of allergic rhinitis symptoms on work performance, assessed by means of Visual Analogue Scale (VAS) work; and (ii) the effect of asthma comorbidity on work productivity.METHODS: We assessed data from the MASK-air mHealth app of patients with allergic rhinitis. We identified factors associated with the impact of allergic symptoms on work productivity through multivariable linear mixed effects models.RESULTS: We studied 260,378 days from 20,724 patients. In multivariable regression models, nasal symptoms showed the strongest association with VAS work (regression coefficient = 0.38 [95%CI = 0.38; 0.38]). Poor rhinitis control, measured by the combined symptom-medication score, was associated with worse VAS work (regression coefficient = 0.96 [95%CI = 0.96; 0.97]). The median VAS work in patients with probable or possible asthma (median = 9, interquartile range = 22 for probable and 23 for possible asthma) was greater than for patients with no evidence of asthma (median = 3, interquartile range = 12) (Cohen's d = 0.60). In patients with probable asthma, nasal and asthma symptoms showed a similar impact on work productivity (regression coefficient for VAS nose = 0.32 [95%CI = 0.31; 0.32]; regression coefficient for VAS asthma = 0.30 [95%CI = 0.29; 0.31]).CONCLUSIONS: Allergy symptoms, especially nasal symptoms, are associated with worse work productivity. In addition, patients with allergic rhinitis and asthma display more impairment in work productivity than patients with allergic rhinitis alone.
AB - BACKGROUND: Allergic rhinitis may impair work productivity. This study aimed to assess (i) the differential impact of allergic rhinitis symptoms on work performance, assessed by means of Visual Analogue Scale (VAS) work; and (ii) the effect of asthma comorbidity on work productivity.METHODS: We assessed data from the MASK-air mHealth app of patients with allergic rhinitis. We identified factors associated with the impact of allergic symptoms on work productivity through multivariable linear mixed effects models.RESULTS: We studied 260,378 days from 20,724 patients. In multivariable regression models, nasal symptoms showed the strongest association with VAS work (regression coefficient = 0.38 [95%CI = 0.38; 0.38]). Poor rhinitis control, measured by the combined symptom-medication score, was associated with worse VAS work (regression coefficient = 0.96 [95%CI = 0.96; 0.97]). The median VAS work in patients with probable or possible asthma (median = 9, interquartile range = 22 for probable and 23 for possible asthma) was greater than for patients with no evidence of asthma (median = 3, interquartile range = 12) (Cohen's d = 0.60). In patients with probable asthma, nasal and asthma symptoms showed a similar impact on work productivity (regression coefficient for VAS nose = 0.32 [95%CI = 0.31; 0.32]; regression coefficient for VAS asthma = 0.30 [95%CI = 0.29; 0.31]).CONCLUSIONS: Allergy symptoms, especially nasal symptoms, are associated with worse work productivity. In addition, patients with allergic rhinitis and asthma display more impairment in work productivity than patients with allergic rhinitis alone.
KW - Humans
KW - Rhinitis, Allergic/epidemiology
KW - Male
KW - Female
KW - Efficiency
KW - Adult
KW - Middle Aged
KW - Asthma/epidemiology
KW - Work Performance
KW - Comorbidity
U2 - 10.1016/j.alit.2024.12.007
DO - 10.1016/j.alit.2024.12.007
M3 - Journal article
C2 - 40175264
SN - 1323-8930
VL - 74
SP - 445
EP - 452
JO - Allergology international : official journal of the Japanese Society of Allergology
JF - Allergology international : official journal of the Japanese Society of Allergology
IS - 3
ER -